Daily non-political popular news in brief.

Delays in cancer diagnosis for children remain poorly understood

Though delays in the diagnosis of cancer in children are short and attributable to clinical presentation and healthcare system complexity, the impact of such delays on prognosis remains unclear, according to a new study.

Read more »

Keywords: delays, cancer, diagnosis, children, remain, poorly, understood, delay, diagnosi

« Previous | Next »

Similar news on "Delays in cancer diagnosis for children remain poorly understood":

1. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
   09-10-2007 · EurekAlert!
   A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood. The research, published by Cell Press in the September issue of the journal Cancer Cell, may be useful for identifying tumor-specific signatures associated with diagnosis, prognosis and treatment of cancer.
   Similar news · Read more »
   
2. Statin drugs may delay progressive artery damage in children
   08-03-2007 · EurekAlert!
   Starting statin therapy as young as age 8 safely and effectively delays the early artery damage caused by familial hypercholesterolemia, according to a Dutch study reported in the Aug. 7 print issue of Circulation: Journal of the American Heart Association.
   Similar news · Read more »
   
3. Magnetic resonance imaging improves breast cancer diagnosis
   03-28-2007 · EurekAlert!
   Women who have been diagnosed with breast cancer in one breast have a higher risk of contracting the disease in their opposite breast as well. However, many tumours still remain undetected when using mammography. Magnetic resonance imaging (MRI) promises better results, as is shown in an inter-national study involving the University of Bonn.
   Similar news · Read more »
   
4. UT Southwestern establishes first U.S. morphea registry and DNA repository for both adults and children
   05-31-2007 · UT Southwestern Medical Center
   Dermatologists at UT Southwestern Medical Center are establishing a DNA repository aimed at people with morphea, a poorly understood, incurable and sometimes disfiguring disease that causes patches of skin to thicken and harden.
   Similar news · Read more »
   
5. A dose of God may help medicine
   11-14-2007 · EurekAlert!
   For some families, the cancer diagnosis of a child strengthens existing religious ties or prompts new ones. Now, a new study by researchers at Brandeis University and the University at Buffalo-SUNY in Pediatric Hematology and Oncology reports that while most pediatric oncologists say they are spiritual, and many are open to connecting with the families of very sick children through religion or spirituality, they typically lack the formal healthcare training that could help them build such bridges.
   Similar news · Read more »
   
6. Chemotherapy appears to delay cancer recurrence following surgery for pancreatic cancer
   01-16-2007 · EurekAlert!
   Use of the drug gemcitabine for chemotherapy significantly delays the recurrence of cancer, compared to no chemotherapy, for patients following pancreatic cancer surgery, according to a study in the January 17 issue of JAMA.
   Similar news · Read more »
   
7. COX-2 inhibitors delay pancreatic cancer precursors in mice
   08-01-2007 · EurekAlert!
   Nimesulide, a cyclooxygenase-2 inhibitor, delays the progression of precancerous pancreatic lesions in mice, according to an article in the Aug. 1 issue of the journal Cancer Research.
   Similar news · Read more »
   
8. Parental surveys boost diagnosis abilities of pediatricians
   09-11-2007 · EurekAlert!
   A simple questionnaire developed at the University of Oregon and requiring no more than 15 minutes of a parent's time before or after a doctor's appointment is credited with a 224-percent increase in referrals of year-old and 2-year-old children with mild developmental delays in a yearlong study.
   Similar news · Read more »
   
9. St. Jude shows gene test not needed if cancer drug given in low doses
   06-19-2007 · EurekAlert!
   Investigators at St. Jude Children's Research Hospital have shown that when the cancer drug irinotecan is given in low doses for multiple days, it eliminates the need to delay treatment to perform costly genetic testing that determines if the patient is at risk for serious treatment side effects, such as neutropenia.
   Similar news · Read more »
   
10. Surviving childhood cancer -- the success story
    01-04-2008 · EurekAlert!
    A diagnosis of childhood cancer 50 years ago meant almost certain death. Now, because of scientific advances, the majority of newly diagnosed children can expect to survive. The current special issue of Chronic Illness, published by SAGE, explores the history and advances of childhood cancer research while looking at an exciting new era of research.
    Similar news · Read more »